pharmaphorum

pharmaphorum Podcast

Science EN ↓ 368 episodes

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Be sure to visit the podcast's website and support the creator: pharmaphorum.podbean.com

Author

pharmaphorum

Category

Science

Podcast website

pharmaphorum.podbean.com

Latest episode

Nov 20, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Turning drug development on its head 21.09.2023

In this instalment of the pharmaphorum podcast, host Jonah Comstock welcomes Alchemab CEO Young Kwon, whose company has a different approach: starting with the healthiest of individuals and studying them to find out why they aren’t sick. Specifically, they’re looking through large data sets of healthy and disease-resistant people and looking for common antibodies that could help us all fight disea...

GLP-1 Weight loss drugs: An overview and update 14.09.2023

On today’s pharmaphorum podcast, Dr. Tim Church, chief medical officer at digital weight loss clinic Wondr Health joins Editor in Chief Jonah Comstock to chat about these new drugs, how they work, and how they're changing the game for patients.

Biopharma’s rapid transition to omnichannel marketing 07.09.2023

In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions...

Partnering for holistic care 31.08.2023

In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strategy at Medisafe. Both companies specialise in digital health and, although different, entered into a partnership at the end of June.

Mapping the landscape of clinical trial regulation 25.08.2023

In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs and what’s currently lacking.

Preparing for the tsunami of healthcare data approaching 15.08.2023

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on healthcare.

Alzheimer’s drugs: An overview and update 10.08.2023

In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks...

Suffering beyond physical effects: inequalities and taboos in prostate cancer 01.08.2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo).

Collaborative perseverance to bring change to medicine access 28.07.2023

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex).

Botanicals in pharma: Potential and pitfalls 27.07.2023

In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new category.  

Clinical trial diversity: An update 13.07.2023

Editor in Chief Jonah Comstock welcomes back returning guest Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbot’s vascular business. Jennifer was on the podcast just over a year ago to talk about the importance of clinical trial diversity, and she’s back with an update on that important topic, as well as some news from Abbott in that area.

Changing personnel dynamics in the pharma world 06.07.2023

In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP of Global Talent and Client Delivery James Nyssen speak with host Jonah Comstock about findings from a recent report by their company on the current personnel dynamics in pharma.

Retaining the human quality of healthcare in DTx 05.07.2023

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic, discussing adoption of digital therapeutics and digital technologies in general in clinical practice, and the impact of the event itself overall.

Focusing on predictability and execution in digital trials 28.06.2023

Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chris Moore. The event seen as a chance to bring the whole industry together, Moore explained how there is an excitement in the industry currently, with more drugs being developed, more conditions being treated – including those not before addressed – and...

Genetic testing update with 23andMe’s Noura Abul-Husn 16.06.2023

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe. 

Headlines and hot topics from ASCO and BIO 09.06.2023

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display. Fresh from the floor of BIO International, Jonah s...

The precision element at the heart of digital transformation 30.05.2023

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul. The company – which has been working in the industry for 13 years now – has most recently been focusing on HCP engagement at a global scale, through use of digital channels.

AI in drug development: A reality check 25.05.2023

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.

Epiphany moments in an industry starved of insights 22.05.2023

Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill. Having met up in Nice in 2022, it was interesting to ‘get up to speed’ a year later. Discussing how the industry is ‘starved’ of insights – with so much data from so many sources, fragmented, regional, and disconnected, that decisions cannot be reached in the timeframes neces...

A closer look at gene therapy with PTC Therapeutics 18.05.2023

 In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock connects with Kylie O’Keefe to talk about gene therapy in rare diseases.  They discuss what different gene therapies have in common and how some particular therapies work. They also talk about what gene therapy means for the industry and for patients, in particularly the paradigm shift of disease-modifying therap...

WWD: Ready, Set, Food! CEO, Daniel Zakowski 11.05.2023

On 21st June, London’s prestigious Royal Society of Medicine will play host to some of the sharpest minds in healthcare as they come together for the inaugural World Without Disease conference, developed by pharmaphorum and the CWWDA. One of these minds is Daniel Zakowski, CEO of Ready, Set, Food!, who will be taking the stage to discuss why preventing childhood food allergies is an important step...

The Hidden Burden of Stigmatised Health Conditions 02.05.2023

Having any chronic health condition is complicated, difficult, and scary. But add in a cultural or social stigma and you create whole new levels of challenge.  In today’s pharmaphorum podcast, brought to you by Cerner Enviza, an Oracle company, editor in chief Jonah Comstock welcomes Nate Way, senior evidence generation lead at Cerner Enviza and James Geary MBA, MHA, a data analyst who also lives...

Creating healthier futures - Reuters Pharma Barcelona 2023 02.05.2023

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.

Inside the new world of healthcare data 20.04.2023

On today’s pharmaphorum podcast, Evidation’s Executive Chair of the Board Deborah Kilpatrick joins host Jonah Comstock to talk about healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. 

Restoring sensitivity to targeted therapies 14.04.2023

In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Simon Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialise long-standing research programmes from Gustav Roussy, Institut Curie, the University of Strasbourg, and Pierre Fabre, to develop drugs that overcome tumour resistance to existing drug treatments.

Listen to the pharmaphorum Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.